Terence Connors Buys Shares of AdaptHealth Corp. (AHCO)

On June 24, 2026, Terence Connors, an insider at AdaptHealth Corp. (NasdaqCM: AHCO), purchased 18,999 shares of the company. The transaction did not appear to be part of a pre-planned trading program. Shares of AdaptHealth were trading near $10.18 on the day of the purchase.

Insider Buying and Selling at AdaptHealth Corp.

Several insiders at AdaptHealth Corp. made similar moves on June 24, 2026. David Solomon Williams III, Bradley Coppens, Theodore Lundberg, Susan Weaver, and Gregory Belinfanti each bought 18,999 shares. These transactions were not executed under pre-planned trading programs.

Other Institutional Activity in AdaptHealth Corp.

Institutional investors have been active in AdaptHealth Corp. OEP Capital Advisors, L.P. increased its holdings by 2,494,518 shares, bringing its total to 16,312,698 shares valued at approximately $194.1 million. BlackRock, Inc. added 247,939 shares, now holding 15,939,953 shares worth about $189.7 million. Reinhart Partners, LLC. boosted its stake by 1,981,198 shares, ending with 10,081,983 shares valued at roughly $120.0 million. Meanwhile, FMR LLC grew its position by 423,256 shares to a total of 8,054,691 shares, valued at approximately $95.9 million.

AdaptHealth Corp. Stock Up 77.7%

As of Saturday, shares of AdaptHealth Corp. (NasdaqCM: AHCO) traded near $10.18. The company has a market capitalization of around $1.4 billion and a forward P/E ratio of 8.75. With a beta of 1.463, the stock has experienced a 52-week low of $8.51 and a high of $13.43. Its 50-day moving average stands at $10.99, while the 200-day moving average is $10.21. The company's current ratio is 0.93, with a quick ratio of 0.61, and a debt-to-equity ratio of 132.11.

Recent Earnings

In its most recent financial results, AdaptHealth Corp. reported revenue of approximately $3.29 billion, reflecting a growth rate of 5.4%. The company, however, posted a net margin of -2.42% and a return on equity of -4.85%. The next earnings report is expected on August 4, 2026.

Analysts Set New Price Targets

Analysts have maintained a positive outlook on AdaptHealth Corp. On May 11, 2026, RBC Capital maintained its 'buy' rating with a price target of $15. Canaccord Genuity and UBS similarly maintained 'buy' ratings with targets of $16 and $14, respectively, on May 6, 2026. The consensus among eight analysts is a 'buy' recommendation, with a mean price target of $14.

About AdaptHealth Corp.

AdaptHealth Corp. is a healthcare company based in Conshohocken, Pennsylvania. It distributes home medical equipment and supplies, providing services across various segments, including Sleep Health, Respiratory Health, and Diabetes Health. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth was founded in 2012 and employs approximately 10,900 people under the leadership of CEO Suzanne M. Foster.

Bottom Line

The insider purchases at AdaptHealth Corp. highlight a potential vote of confidence from within the company. Investors often track such transactions as part of their due diligence. While these filings provide historical insights, they may not necessarily reflect the company's current position.